The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at www.Vicus.com, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Reviewing the antidepressant effects of omega-3 fatty acids

    Researchers from Chang Gung University College of Medicine in Taiwan reassessed the results (meta-analysis) from 10 double blind, placebo-controlled studies in more than 300 patients with mood disorders treated with omega-3 PUFAs for at least 4 weeks.

    Here’s what they found.

    • Taking omega-3 fatty acids significantly improved depression in patients with clearly defined depression or with bipolar disorder.
    • The dosage of eicosapentaenoic acid (EPA) did not change the antidepressant efficacy.

    The bottom line?
    They also found “significant heterogeneity among these studies and publication bias.” In other words, there were enough irregularities in the design and reporting of the results that more research is required to define the patients most likely to respond to omega 3, the proper dose, and the best composition of omega 3 fatty acids to use.

    8/10/07 18:05 JR

    Leave a Comment

    You must be logged in to post a comment.